Dave(DAVE) GlobeNewswire News Room·2025-03-18 13:00Core Insights - NeuroOne Medical Technologies Corporation is focused on improving surgical care for patients with neurological disorders, particularly epilepsy, through innovative technology [1][5] - The OneRF® Ablation System is a significant advancement in epilepsy treatment, being the first FDA 510(k)-cleared device that can record brain activity and perform RF ablation simultaneously [3][4] Industry Overview - Over 50 million people globally are affected by epilepsy, with nearly one-third experiencing medication-resistant seizures, highlighting the need for alternative treatment options like RF ablation therapy [2] - The medical technology sector is increasingly focusing on minimally invasive solutions for neurological disorders, which may lead to improved patient outcomes and reduced procedural costs [5] Company Developments - The OneRF® system includes an electrode for brain activity monitoring, a temperature probe, and a radio frequency heat generator, enhancing the efficiency and precision of epilepsy treatments [3][4] - NeuroOne is also exploring the potential applications of its technology in pain management and other neurological conditions, indicating a broader market strategy [5]